Literature DB >> 7619523

Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of determinants of alpha-conotoxin M1 selectivity.

S M Sine1, H J Kreienkamp, N Bren, R Maeda, P Taylor.   

Abstract

The acetylcholine receptor from vertebrate skeletal muscle is a pentamer of homologous subunits with composition alpha 2 beta gamma delta. Its two ligand binding sites, formed at alpha-gamma and alpha-delta interfaces, differ in their affinities for agonists and competitive antagonists, owing to different contributions of the gamma and delta subunits. To identify portions of the gamma and delta subunits that contribute to the binding sites, the experiments described here use gamma-delta subunit chimeras and site-specific mutants to determine the basis of the 10,000-fold selectivity of conotoxin M1 for the sites. Three distinct regions of the extracellular domain were found to contribute to conotoxin M1 selectivity, each containing a single residue responsible for the contribution of that region. Residues K34, S111, and F172 of the gamma subunit confer low affinity to the alpha-gamma binding site, whereas the corresponding residues of the delta subunit, S36, Y113, and I178, confer high affinity to the alpha-delta site. Identification of three separate determinants of ligand selectivity suggests a limited model of the folding pattern of the extracellular domain of the subunits.

Mesh:

Substances:

Year:  1995        PMID: 7619523     DOI: 10.1016/0896-6273(95)90077-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  37 in total

1.  Electrostatic interactions regulate desensitization of the nicotinic acetylcholine receptor.

Authors:  X Z Song; S E Pedersen
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

2.  Alternatively spliced variants of gamma-subunit of muscle-type acetylcholine receptor in fetal and adult skeletal muscle of mouse.

Authors:  Shafquat Azim; Abdul Rouf Banday; Tarique Sarwar; Mohammad Tabish
Journal:  Cell Mol Neurobiol       Date:  2012-04-10       Impact factor: 5.046

3.  Acetylcholine receptor channels activated by a single agonist molecule.

Authors:  Archana Jha; Anthony Auerbach
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

4.  Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation.

Authors:  Corrie J B daCosta; Chris R Free; Jeremías Corradi; Cecilia Bouzat; Steven M Sine
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 5.  Molecular investigations on the nicotinic acetylcholine receptor: conformational mapping and dynamic exploration using photoaffinity labeling.

Authors:  F Kotzyba-Hibert; T Grutter; M Goeldner
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

6.  A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.

Authors:  Russell W Teichert; Jean Rivier; Josep Torres; John Dykert; Charleen Miller; Baldomero M Olivera
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

7.  Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors.

Authors:  Diego Rayes; María José De Rosa; Steven M Sine; Cecilia Bouzat
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

Review 8.  Allosteric activation mechanism of the cys-loop receptors.

Authors:  Yong-chang Chang; Wen Wu; Jian-liang Zhang; Yao Huang
Journal:  Acta Pharmacol Sin       Date:  2009-05-11       Impact factor: 6.150

9.  The interface between extracellular and transmembrane domains of homomeric Cys-loop receptors governs open-channel lifetime and rate of desensitization.

Authors:  Cecilia Bouzat; Mariana Bartos; Jeremías Corradi; Steven M Sine
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

Review 10.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.